Today: 1 May 2026
Browse Category

Stock Market 23 January 2026

Robo.ai stock price jumps before the bell on Ghazi Group AI infrastructure deal (AIIO)

Robo.ai stock price jumps before the bell on Ghazi Group AI infrastructure deal (AIIO)

Robo.ai shares jumped about 25% to 33 cents in premarket trading Friday after announcing a three-year reseller deal with The Ghazi Group targeting MENA and Southeast Asia, with projected revenue over $100 million. The stock remains below Nasdaq’s $1 minimum, leaving the company at risk of delisting if it fails to regain compliance by June 8, 2026.
Redwire stock price today: RDW jumps in premarket after 17% surge as “Golden Dome” focus returns

Redwire stock price today: RDW jumps in premarket after 17% surge as “Golden Dome” focus returns

Redwire Corp shares rose 9.9% premarket Friday after surging 17.5% Thursday, trading at $13.16. The rally follows renewed focus on the U.S. “Golden Dome” missile-defense system, with Redwire bidding for project work valued at $542 billion. H.C. Wainwright maintained its $22 price target. The company is restructuring and retiring the Edge Autonomy brand.
Zillow stock jumps nearly 6% as fresh housing forecast lifts focus into earnings

Zillow stock jumps nearly 6% as fresh housing forecast lifts focus into earnings

Zillow Group’s Class C shares rose 5.7% Thursday and traded near $68.59 premarket Friday after the company forecast a 1.2% rise in U.S. home values and a 4.3% increase in existing-home sales for 2026. Benchmark raised its Zillow price target to $110, citing expected housing catalysts. Compass, now merged with Anywhere, is expanding private listings and seeking a legal injunction against Zillow.
Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences shares rose about 2% premarket after an SEC filing showed FDA agreement on a single adaptive Phase 2/3 trial for its Gemini program in acute kidney injury. The company said strong results from roughly 300 patients could support a U.S. approval filing. Shares last traded near $0.85. Investors remain focused on trial timing and the firm’s $12.7 million cash position.
US economic calendar today: Intel slides, Wall Street futures dip ahead of PMI and Michigan sentiment

US economic calendar today: Intel slides, Wall Street futures dip ahead of PMI and Michigan sentiment

U.S. stock futures slipped early Friday after Intel shares plunged 13.6% on a weak outlook. At 5:57 a.m. ET, S&P 500 E-minis were down 0.23%, Nasdaq 100 E-minis fell 0.35%, and Dow E-minis dropped 0.24%. Investors await key PMI data and the Michigan sentiment index later this morning. Intuitive Surgical rose 3.7% premarket after beating earnings estimates.
23 January 2026
Intel stock plunges in premarket, putting AI chip stocks and prices in play ahead of Big Tech earnings

Intel stock plunges in premarket, putting AI chip stocks and prices in play ahead of Big Tech earnings

Intel fell 13.6% in premarket trading after warning of supply shortages for AI data-center chips, erasing up to $31 billion in market value. Nasdaq 100 futures dropped 0.35% by 5:57 a.m. ET. Investors are watching a packed earnings week for signs that AI spending is translating into profit growth. Memory-chip prices are rising as AI infrastructure strains supply chains.
UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

The FTSE 100 fell 0.13% to 10,136.43 on Friday, reversing early gains as strong UK retail sales and a jump in business activity fueled speculation the Bank of England may delay rate cuts. Retail sales rose 0.4% in December, beating forecasts, while the UK Composite PMI hit 53.9, its highest since April 2024. Babcock shares slipped 1.2% after its CEO announced plans to retire. C&C Group dropped 9.6% on a profit warning.
CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics shares slipped 0.5% to $60.51 in premarket trading Friday after CEO Samarth Kulkarni sold 90,000 shares for about $5.2 million under a preset plan, an SEC filing showed. The stock had surged 11.1% Thursday on heavy volume. Options trading spiked, with focus on April $90 calls. Bank of America trimmed its price target to $89 but kept a Buy rating.
Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Ltd shares rose 1.03% to 5,833.25 rupees after reporting a 40% year-on-year profit jump to 163.54 crore rupees for the December quarter, with revenue up 11% to 1,573.62 crore. Operating expenses climbed 2.9% from the previous quarter, and employee benefit costs surged due to a 41.35 crore rupee provision for new labour codes. Indian stocks closed lower, with the Nifty 50 down 0.95%.
CSGS stock price inches from NEC’s $80.70 deal — what traders watch before the Jan. 30 vote

CSGS stock price inches from NEC’s $80.70 deal — what traders watch before the Jan. 30 vote

CSG Systems closed Thursday at $79.83, just below NEC’s $80.70-per-share cash offer ahead of a Jan. 30 shareholder vote on the deal. The stock hit a 52-week high of $80.28 during the session. SEC filings show CEO Brian Shepherd and CFO Hai Tran received restricted stock grants dated Jan. 20. NEC’s $2.89 billion acquisition awaits shareholder and regulatory approval.
23 January 2026

Stock Market Today

  • Australian Shares Expected to Rise as US Markets Hit Record Highs and Corporate Earnings Impress
    May 1, 2026, 1:25 AM EDT. Australian sharemarket futures surged 131 points to 8,677, reflecting optimism after Wall Street's record-breaking session where the Dow Jones rose 1.62% and the S&P 500 posted its strongest monthly gain since November 2020. Persistent gains in tech and industrial giants, including Atlassian, Apple, and Caterpillar, bolstered investor confidence. Brent crude oil briefly hit $126 a barrel amid Middle East tensions before settling down slightly. The Australian dollar strengthened to 72 US cents, with Bitcoin modestly up. Locally, attention shifts to March producer price indexes from the Australian Bureau of Statistics, while US economic data showed 2% GDP growth in Q1 2026 alongside rising inflation at 3.5%. The mix of robust earnings and macroeconomic signals sets the stage for a rally in Australian equities.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 1:34 AM EDT Australian Shares Expected to Rise as US Markets Hit Record Highs and Corporate Earnings Impress May 1, 2026, 1:25 AM EDT. Australian sharemarket futures surged 131 points to 8,677, reflecting optimism after Wall Street's record-breaking session where the Dow Jones rose 1.62% and the S&P 500 posted its strongest monthly gain since November 2020. Persistent gains in tech and industrial giants, including Atlassian, Apple, and Caterpillar, bolstered investor confidence. Brent crude oil briefly hit $126 a barrel amid Middle East tensions before settling down slightly.
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop